Facilitating global surveillance of antimicrobial resistance and use

 

 

 

The Global Antimicrobial Resistance and Use Surveillance System (GLASS) promotes and supports a standardized approach to the collection, analysis and sharing of antimicrobial resistance (AMR) and antimicrobial consumption (AMC) data at a global level. It encourages and facilitates the establishment of national surveillance systems to monitor AMR and AMU trends and produce reliable and comparable data to build the evidence base on AMR and help inform decision making. 

Launched in October 2015, GLASS initially focused on surveillance of data on human priority bacterial pathogens considered the greatest threat globally. It has already included surveillance of antimicrobial use and progressively incorporates other related surveillance targets and data; including the Emerging Antimicrobial Resistance Reporting (GLASS-EAR) component.

Countries are encouraged to join GLASS with the agreement of their national government and once their participation is confirmed can benefit from access to global data, guidance, tools and support for national surveillance systems and laboratories as they build effective surveillance systems.

GLASS is working in collaboration with WHO Regional Offices and is supported by a network of WHO Collaborating Centres, involving strong commitment from participating countries and close collaboration with AMR regional networks.

Detailed information regarding country participation is also available.